Szerző: " Szalárdy Levente"

Szalárdy Levente; Fakan Bernadett; Török Rita; Ferencz Emil; Reisz Zita; Radics Bence; Csizmadia Sandor; Szpisjak László; Annus Ádám; Zádori Dénes; Kovács Gábor G.; Klivényi Péter: Identifying diagnostic and prognostic factors in cerebral amyloid angiopathy-related inflammation : a systematic analysis of published and seven new cases.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 50 (1). ISSN 0305-1846 (2024)

Majláth Zsófia; Szalárdy Levente; Zádori Dénes; Klivényi Péter; Fülöp Ferenc; Toldi József; Vécsei László: Neuroprotection by Kynurenine Metabolites.
In: Handbook of Neurotoxicity. Springer, Cham, pp. 1067-1080. (2022) ISBN 9783031150791; 9783031150807

Momtazmanesh Sara; Shobeiri Parnian; Saghazadeh Amene; Teunissen Charlotte E.; Burman Joachim; Szalárdy Levente; Klivényi Péter; Bartos Ales; Fernandes Adelaide; Rezaei Nima: Neuronal and glial CSF biomarkers in multiple sclerosis.
REVIEWS IN THE NEUROSCIENCES, 32 (6). pp. 573-595. ISSN 0334-1763 (2021)

Zádori Dénes; Szalárdy Levente; Reisz Zita; Kovács Gábor Géza; Török Rita; Ajeawung Norbert F.; Vécsei László; Campeau Philippe M.; Klivényi Péter: Clinicopathological Relationships in an Aged Case of DOORS Syndrome With a p.Arg506X Mutation in the ATP6V1B2 Gene.
FRONTIERS IN NEUROLOGY, 11. Azonosító: 767-Terjedelem: 9 p. ISSN 1664-2295 (2020)

Fakan Bernadett; Reisz Zita; Zádori Dénes; Vécsei László; Klivényi Péter; Szalárdy Levente: Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages.
JOURNAL OF NEURAL TRANSMISSION, 127 (6). pp. 963-972. ISSN 0300-9564 (2020)

Babarczy Kristóf; Reisz Zita; Szabó Elza; Rajda Cecília; Vécsei László; Bódi István; Klivényi Péter; Hortobágyi Tibor; Szalárdy Levente: A longitudinally extensive H3 K27M-mutant diffuse midline glioma in an elderly patient clinically mimicking central nervous system inflammation: a case report.
FOLIA NEUROPATHOLOGICA, 58 (4). pp. 377-385. ISSN 1641-4640 (2020)

Cseh Edina Katalin; Veres Gábor; Danics Krisztina; Szalárdy Levente; Nánási Nikolett; Klivényi Péter; Vécsei László; Zádori Dénes: Additional value of TAU protein measurement in the diagnosis of Creutzfeldt-Jakob Disease [A tau fehérje meghatározás kiegészítő szerepe a Creutzfeldt-Jakob-betegség diagnosztikájában].
IDEGGYOGYASZATI SZEMLE / CLINICAL NEUROSCIENCE, 72 (1/2). pp. 39-47. ISSN 0019-1442 (2019)

Fakan Bernadett; Szalárdy Levente; Vécsei László: Exploiting the Therapeutic Potential of Endogenous Immunomodulatory Systems in Multiple Sclerosis.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 20 (2). Azonosító: 426-Terjedelem: 25 p. ISSN 1661-6596 (2019)

Zádori Dénes; Veres Gábor; Szalárdy Levente; Klivényi Péter; Vécsei László: Alzheimer's disease: recent concepts on the relation of mitochondrial disturbances, excitotoxicity, neuroinflammation, and kynurenines.
JOURNAL OF ALZHEIMER'S DISEASE, 62 (2). pp. 523-547. ISSN 1387-2877 (2018)

Szalárdy Levente; Fort Molnár Máté; Zádori Dénes; Cseh Edina; Veres Gábor; Kovács Gábor G.; Vécsei László; Klivényi Péter: Non-motor behavioral alterations of PGC-1 alpha-deficient mice - a peculiar phenotype with slight male preponderance and no apparent progression.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 12. Terjedelem: 13 p. -Azonosító: 180. ISSN 1662-5153 (2018)

Edvinsson Lars; Tajti János; Szalárdy Levente; Vécsei László: PACAP and its role in primary headaches.
JOURNAL OF HEADACHE AND PAIN, 19 (1). Terjedelem: 15 p. -Azonosító: 21. ISSN 1129-2369 (2018)

Szalárdy Levente; Zádori Dénes; Bencsik Krisztina; Vécsei László; Klivényi Péter: Unlike PPARgamma, neither other PPARs nor PGC-1alpha is elevated in the cerebrospinal fluid of patients with multiple sclerosis.
NEUROSCIENCE LETTERS, 651. pp. 128-133. ISSN 0304-3940 (2017)

Fort Molnár Máté; Török Rita; Szalárdy Levente; Sümegi Evelin; Vécsei László; Klivényi Péter: High-dose 1,25-dihydroxyvitamin D supplementation elongates the lifespan of Huntington's disease transgenic mice.
Acta Neurobiologiae Experimentalis, 76 (3). pp. 176-181. ISSN 0065-1400 (2016)

Szalárdy Levente; Fort Molnár Máté; Török Rita; Zádori Dénes; Vécsei László; Klivényi Péter; Liberski Paweł Piotr; Kovács Gábor Géza: Histopathological comparison of Kearns-Sayre syndrome and PGC-1α-deficient mice suggests a novel concept for vacuole formation in mitochondrial encephalopathy.
FOLIA NEUROPATHOLOGICA, 54 (1). pp. 9-22. ISSN 1641-4640 (2016)

Zádori Dénes; Veres Gábor; Szalárdy Levente; Klivényi Péter; Fülöp Ferenc; Toldi József; Vécsei László: Inhibitors of the kynurenine pathway as neurotherapeutics: A patent review (2012–2015).
EXPERT OPINION ON THERAPEUTIC PATENTS, 26 (7). pp. 815-832. ISSN 1354-3776 (2016)

Török Nóra; Majláth Zsófia; Szalárdy Levente; Vécsei László: Investigational α-synuclein aggregation inhibitors: hope for Parkinson’s disease.
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 25 (11). pp. 1281-1294. ISSN 1354-3784 (2016)

Szalárdy Levente; Molnár Máté; Török Rita; Zádori Dénes; Kovács Gábor Géza; Vécsei László; Klivényi Péter: Lack of age-related clinical progression in PGC-1α-deficient mice – implications for mitochondrial encephalopathies.
Behavioural Brain Research, 313. pp. 272-281. ISSN 0166-4328 (2016)

Szalárdy Levente; Klivényi Péter; Zádori Dénes; Fülöp Ferenc; Toldi József; Vécsei László: Mitochondrial Disturbances, Tryptophan Metabolites and Neurodegeneration: Medicinal Chemistry Aspects.
Current Medicinal Chemistry, 19 (13). pp. 1899-1920. ISSN 0929-8673 (2016)

Szalárdy Levente; Zádori Dénes; Klivényi Péter; Vécsei László: The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer's Disease: Shortcomings in Prodromal Diagnosis.
Journal of Alzheimer's Disease, 53 (2). pp. 373-392. ISSN 1387-2877 (2016)

Veres Gábor; Fort Molnár Máté; Zádori Dénes; Szentirmai Márton; Szalárdy Levente; Török Rita; Fazekas Emese; Ilisz István; Vécsei László; Klivényi Péter: Central nervous system-specific alterations in the tryptophan metabolism in the 3-nitropropionic acid model of Huntington's disease.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 132. pp. 115-124. ISSN 0091-3057 (2015)

Zádori Dénes; Veres Gábor; Szalárdy Levente; Klivényi Péter; Vécsei László: Drug-induced movement disorders.
Expert Opinion on Drug Safety, 14 (6). pp. 877-890. ISSN 1474-0338 (2015)

Szalárdy Levente; Zádori Dénes; Klivényi Péter; Toldi József; Vécsei László: Electron Transport Disturbances and Neurodegeneration: From Albert Szent-Gyorgyi's Concept (Szeged) till Novel Approaches to Boost Mitochondrial Bioenergetics.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2015. Terjedelem: 19 p.-Azonosító: 498401. ISSN 1942-0900 (2015)

Török Rita; Kónya Júlia Anna; Zádori Dénes; Veres Gábor; Szalárdy Levente; Vécsei László; Klivényi Péter: mRNA Expression Levels of PGC-1alpha in a Transgenic and a Toxin Model of Huntington's Disease.
CELLULAR AND MOLECULAR NEUROBIOLOGY, 35 (2). pp. 293-301. ISSN 0272-4340 (2015)

Zádori Dénes; Veres Gábor; Szalárdy Levente; Klivényi Péter; Toldi József; Vécsei László: Glutamatergic dysfunctioning in Alzheimer's disease and related therapeutic targets.
Journal of Alzheimer's disease : JAD, 42 (Suppl. 3.). S177-S187. ISSN 1387-2877 (2014)

Plangár Imola; Zádori Dénes; Szalárdy Levente; Vécsei László; Klivényi Péter: Assessment of the role of multidrug resistance-associated proteins in MPTP neurotoxicity in mice.
Ideggyógyászati Szemle, 66 (11-12). pp. 407-4014. ISSN 0019-1442 (2013)

Török Rita; Török Nóra; Szalárdy Levente; Plangár Imola; Szolnoki Zoltán; Somogyvári Ferenc; Vécsei László; Klivényi Péter: Association of vitamin D receptor gene polymorphisms and Parkinson's disease in Hungarians.
Neuroscience Letters, 551. pp. 70-74. ISSN 0304-3940 (2013)

Szalárdy Levente; Zádori Dénes; Tánczos Ervin; Simu Mihaela; Bencsik Krisztina; Vécsei László; Klivényi Péter: Elevated levels of PPAR-gamma in the cerebrospinal fluid of patients with multiple sclerosis.
Neuroscience Letters, 554. pp. 131-134. ISSN 0304-3940 (2013)

Szalárdy Levente; Zádori Dénes; Simu Mihaela; Bencsik Krisztina; Vécsei László; Klivényi Péter: Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severity.
Journal of the Neurological Sciences, 331 (1-2). pp. 38-42. ISSN 0022-510X (2013)

Vécsei László; Szalárdy Levente; Fülöp Ferenc; Toldi József: Kynurenines in the CNS: recent advances and new questions.
Nature Reviews Drug Discovery, 12 (1). pp. 64-82. ISSN 1474-1776 (2013)

Szalárdy Levente; Zádori Dénes; Plangár Imola; Vécsei László; Weydt Patrick; Ludolph Albert C.; Klivényi Péter; Kovács Gábor G.: Neuropathology of partial PGC-1alpha deficiency recapitulates features of mitochondrial encephalopathies but not of neurodegenerative diseases.
Neurodegenerative Diseases, 12 (4). pp. 177-188. ISSN 1660-2854 (2013)

Zádori Dénes; Szalárdy Levente; Toldi József; Fülöp Ferenc; Klivényi Péter; Vécsei László: Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson’s disease.
Journal of Neural Transmission, 120 (4). pp. 673-681. ISSN 0300-9564 (2013)

Szalárdy Levente; Zádori Dénes; Toldi József; Fülöp Ferenc; Klivényi Péter; Vécsei László: Manipulating Kynurenic Acid Levels in the Brain - On the Edge Between Neuroprotection and Cognitive Dysfunction.
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 12 (16). pp. 1791-1806. ISSN 1568-0266 (2012)

Zádori Dénes; Klivényi Péter; Szalárdy Levente; Fülöp Ferenc; Toldi József; Vécsei László: Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: Novel therapeutic strategies for neurodegenerative disorders.
Journal of the Neurological Sciences, 322 (1-2). pp. 187-191. ISSN 0022-510X (2012)